Critically appraising the cass report: methodological flaws and unsupported claims
Chris Noone, Alex Southgate, Alex Ashman et al. · BMC Medical Research Methodology · 2025
BACKGROUND: The Cass Review aimed to provide recommendations for the delivery of services for gender diverse children and young people in England. The final product of this project, the Cass report, relied on commissioned research output, including quantitative and qualitative primary research as well as seven systematic reviews, to inform its recommendations and conclusions. METHODS: We critically evaluated the Cass report and the research that was commissioned to inform it. To evaluate the Risk of Bias within the seven systematic reviews commissioned by the Cass Review, we applied the ROBIS tool - a domain-based assessment of risk of bias within systematic reviews. It focuses on four domains (i) study eligibility criteria, (ii) identification and selection of studies, (iii) data collection and study appraisal, and (iv) synthesis and findings. To maintain rigour, the ROBIS tool was applied to each systematic review by two independent assessors, within Covidence, with conflicts resolved by an additional two independent assessors. We also conducted a detailed critical evaluation of the methods used in the survey of gender services for young people in Europe, the two quantitative studies of health records, and the qualitative study on the experience of gender dysphoria among young people and the claims made in the Cass report based on these studies. RESULTS: Using the ROBIS tool, we identified a high risk of bias in each of the systematic reviews driven by unexplained protocol deviations, ambiguous eligibility criteria, inadequate study identification, and the failure to integrate consideration of these limitations into the conclusions derived from the evidence syntheses. We also identified methodological flaws and unsubstantiated claims in the primary research that suggest a double standard in the quality of evidence produced for the Cass report compared to quality appraisal in the systematic reviews. CONCLUSIONS: We discuss these issues in relation to how evidence regarding gender affirming care is framed, the wider political context, and the future for gender affirming care. The Cass report's recommendations, given its methodological flaws and misrepresentation of evidence, warrant critical scrutiny to ensure ethical and effective support for gender-diverse youth.
Cited by 50 works. doi:10.1186/s12874-025-02581-7 Open-access PDF
Authors
- Chris Noone
- Alex Southgate
- Alex Ashman
- Éle Quinn
- Duncan Shrewsbury
- Florence Ashley
- Jo Hartland
- Joanna Paschedag
- John Gilmore
- Natacha Kennedy
- Thomas E. Woolley
- Rachel Heath
- Ryan Goulding
- Victoria Simpson
- Ed Kiely
- Sibéal Coll
- Margaret E. White
- Dori M. Grijseels
- Maxence Ouafik
References
- Cochrane Handbook for Systematic Reviews of Interventions
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
- Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
- AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both
- AGREE II: advancing guideline development, reporting and evaluation in health care
- ROBIS: A new tool to assess risk of bias in systematic reviews was developed
- Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
- The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers
- Standards of Care for the Health of Transgender and Gender Diverse People, Version 8